UNSPSC 51172021: Cinnarizine + calcium dobesilate

Non-proliferative diabetic retinopathy.

UNSPSC 51172021 Cinnarizine + calcium dobesilate is a Commodity code that describes a pharmaceutical combination product, but recent state and local procurement activity under this code does not reflect pharmaceutical procurement. Collin County Community Supervision and Corrections Department in Texas posted RFP 2026-327 for offender specimen collection and drug testing services—a work scope centered on staffing collection sites, operating randomized testing notification systems, conducting immunoassay screening with confirmatory testing (LC/MS/MS or GC/MS), and reporting results. The solicitation encompasses specimen collection, laboratory analysis, and ancillary testing methodologies including oral fluid and hair testing, none of which aligns with the acquisition of cinnarizine or calcium dobesilate pharmaceuticals. This code shows little relevant recent activity for its stated pharmaceutical scope; the single recent opportunity represents a categorical mismatch between the UNSPSC designation and the actual work being bought.

The Collin County RFP is the only recent state or local opportunity identified under this code. Proposals were due July 23, 2026, with an anticipated award date of August 10, 2026. The estimated contract value is $600,000 over a two-year initial term with three optional one-year renewals, not to exceed five years total. Pricing is submitted on a per-test basis (approximately 25,031 annual tests), and the successful vendor must maintain lab certification from SAMHSA, TX DPS, or CAP. The contract is funded through Texas Department of Criminal Justice appropriations and is subject to annual availability. Business development professionals should verify whether this code is the appropriate filter for pharmaceutical procurement; the mismatch suggests either miscoding in the state or local system or a data alignment issue.